{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T18:09:55Z","timestamp":1778350195640,"version":"3.51.4"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Backgrounds<\/jats:title>\n<jats:p>In order to move towards the elimination and eradication of malaria in the world, the development of vaccines is inevitable. Many modern vaccines are based on recombinant technology; however, they may not provide a fully protective, long-lasting immune response. One of the strategies to improve recombinant vaccines is designing the nanovaccines such as self-assembling protein nanoparticles (SAPNs). Hence, the presentation of epitopes in a repeat array and correct conformation should be considered. <jats:italic>P<\/jats:italic>. <jats:italic>falciparum<\/jats:italic> generative cell-specific 1 (PfGCS1) is a main transmission-blocking vaccine candidate with two highly conserved fragments, HAP2-GCS1 and cd loop, inducing partial malaria transmission inhibitory antibodies. Therefore, to design an effective malaria vaccine, we used cd loop and HAP2-GCS1 fragments at the amino and carboxy terminuses of the SAPN-forming amino acid sequence, respectively.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methodology\/Principal findings<\/jats:title>\n<jats:p>The SAPN monomer (PfGCS1-SAPN) sequence was designed, and the three-dimensional (3D) structure was predicted. The result of this prediction ensured the presence of antigens on the SAPN surface. Then the accuracy of the predicted 3D structure and its stability were confirmed by 100 ns molecular dynamics (MD) simulation. The designed SAPN substructure sequence was synthesized, cloned, and expressed in <jats:italic>Escherichia coli<\/jats:italic>. With a gradual decrease in urea concentration in dialysis solutions, the purified proteins progressed to the final desired structure of the SAPN, which then was confirmed by Dynamic Light Scattering (DLS) and Field Emission Scanning Electron Microscopy (FESEM) tests. According to the Enzyme-Linked Immunosorbent Assay (ELISA), antigenic determinants were presented on the SAPN surface and interacted with antibodies in the serum of malaria patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions\/Significance<\/jats:title>\n<jats:p>Our results show that the SAPN formed by PfGCS1-SAPN has produced the correct shape and size, and the antigenic determinants are presented on the surface of the SAPN, which indicates that the designed SAPN has great potential to be used in the future as a malaria vaccine.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0274275","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T17:31:30Z","timestamp":1663003890000},"page":"e0274275","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Design and development of a self-assembling protein nanoparticle displaying PfHAP2 antigenic determinants recognized by natural acquired antibodies"],"prefix":"10.1371","volume":"17","author":[{"given":"Farhad","family":"Zahedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9502-0407","authenticated-orcid":true,"given":"Akram","family":"Abouie Mehrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soroush","family":"Sardari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iran","family":"Alemzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,9,12]]},"reference":[{"key":"pone.0274275.ref001","doi-asserted-by":"crossref","first-page":"e3071","DOI":"10.1371\/journal.pntd.0003071","article-title":"Is Plasmodium vivax Malaria a Severe Malaria?: A Systematic Review and Meta-Analysis","volume":"8","author":"C Naing","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"pone.0274275.ref002","doi-asserted-by":"crossref","first-page":"17050","DOI":"10.1038\/nrdp.2017.50","article-title":"Malaria","volume":"3","author":"MA Phillips","year":"2017","journal-title":"Nat Rev Dis Prim"},{"key":"pone.0274275.ref003","author":"WHO","year":"2021","journal-title":"Word Malaria Report 2021"},{"key":"pone.0274275.ref004","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cell.2016.07.055","article-title":"Malaria: Biology and Disease","volume":"167","author":"AF Cowman","year":"2016","journal-title":"Cell"},{"key":"pone.0274275.ref005","doi-asserted-by":"crossref","first-page":"e1000398","DOI":"10.1371\/journal.pmed.1000398","article-title":"A Research Agenda for Malaria Eradication: Vaccines","volume":"8","author":"The malERA Consultative Group on Vaccines","year":"2011","journal-title":"PLoS Med"},{"key":"pone.0274275.ref006","doi-asserted-by":"crossref","first-page":"e1002455","DOI":"10.1371\/journal.pmed.1002455","article-title":"malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication","volume":"14","author":"Elimination malERA RCP on T for M","year":"2017","journal-title":"PLoS Med"},{"key":"pone.0274275.ref007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.05.001","article-title":"Vaccine Technologies: From Whole Organisms to Rationally Designed Protein Assemblies","volume":"120","author":"CP Karch","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"pone.0274275.ref008","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2174\/156720111795256192","article-title":"Peptide-Based Subunit Nanovaccines","volume":"8","author":"M Skwarczynski","year":"2011","journal-title":"Curr Drug Deliv"},{"key":"pone.0274275.ref009","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.vaccine.2005.01.142","article-title":"Towards an RTS, S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research \u0b1d","volume":"23","author":"DG Heppner","year":"2005","journal-title":"Vaccine"},{"key":"pone.0274275.ref010","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1515257","article-title":"Seven-year efficacy of RTS, S\/AS01 malaria vaccine among young African children","volume":"374","author":"A Olotu","year":"2016","journal-title":"N Engl J Med"},{"key":"pone.0274275.ref011","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1586\/14760584.2015.1096781","article-title":"Malaria vaccine based on self-assembling protein nanoparticles","volume":"14","author":"P Burkhard","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"pone.0274275.ref012","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3389\/fimmu.2018.00598","article-title":"Distinct immunologic Properties of Soluble versus Particulate Antigens","volume":"9","author":"CM Snapper","year":"2018","journal-title":"Front Immunol"},{"key":"pone.0274275.ref013","first-page":"1","article-title":"Introduction to Nanoparticles","author":"S Horikoshi","year":"2013","journal-title":"Microwaves Nanoparticle Synth Fundam Appl"},{"key":"pone.0274275.ref014","volume-title":"Nanomedicine and Cancer","author":"R Srirajaskanthan","year":"2012"},{"key":"pone.0274275.ref015","author":"J Punt","year":"2019","journal-title":"Kuby Immunology"},{"key":"pone.0274275.ref016","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI81083","article-title":"Beyond antigens and adjuvants: formulating future vaccines","volume":"126","author":"TJ Moyer","year":"2016","journal-title":"J Clin Invest"},{"key":"pone.0274275.ref017","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"MF Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"pone.0274275.ref018","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jconrel.2014.07.060","article-title":"Novel self assembling nanoparticles for the oral administration of fondaparinux: Synthesis, characterization and in vivo evaluation","volume":"194","author":"B Ralay-Ranaivo","year":"2014","journal-title":"J Control Release"},{"key":"pone.0274275.ref019","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.nano.2016.08.030","article-title":"Vaccination with self-adjuvanted protein nanoparticles provides protection against lethal influenza challenge","volume":"13","author":"CP Karch","year":"2017","journal-title":"Nanomedicine Nanotechnology, Biol Med."},{"key":"pone.0274275.ref020","first-page":"761","article-title":"The Crystal Structure of a Five-Stranded Coiled Coil in COMP: A Prototype Ion Channel? Author (s): Vladimir N. Malashkevich, Richard A. Kammerer, Vladimir P. Efimov","volume":"274","author":"VN Malashkevich","year":"1996","journal-title":"Therese Schulthess and J\u00fcrgen Engel Published by: American Association for the. Science"},{"key":"pone.0274275.ref021","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1747-0285.2008.00746.x","article-title":"Peptide Nanoparticles as Novel Immunogens: Design and Analysis of a Prototypic Severe Acute Respiratory Syndrome Vaccine","volume":"73","author":"TAPF Pimentel","year":"2009","journal-title":"Chem Biol Drug Des"},{"key":"pone.0274275.ref022","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.4049\/jimmunol.0901957","article-title":"A Nonadjuvanted Polypeptide Nanoparticle Vaccine Confers Long-Lasting Protection against Rodent Malaria","volume":"183","author":"SA Kaba","year":"2009","journal-title":"J Immunol"},{"key":"pone.0274275.ref023","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ncb1345","article-title":"GENERATIVE CELL SPECIFIC 1 is essential for angiosperm fertilization","volume":"8","author":"T Mori","year":"2006","journal-title":"Nat Cell Biol"},{"key":"pone.0274275.ref024","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cub.2008.03.045","article-title":"Male Fertility of Malaria Parasites Is Determined by GCS1, a Plant-Type Reproduction Factor","volume":"18","author":"M Hirai","year":"2008","journal-title":"Curr Biol"},{"key":"pone.0274275.ref025","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1016\/j.vaccine.2009.06.069","article-title":"Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in vivo and in vitro","volume":"27","author":"AM Blagborough","year":"2009","journal-title":"Vaccine"},{"key":"pone.0274275.ref026","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1101\/gad.1656508","article-title":"The conserved plant sterility gene HAP2 functions after attachment of fusogenic membranes in Chlamydomonas and Plasmodium gametes","volume":"22","author":"Y Liu","year":"2008","journal-title":"Genes Dev"},{"key":"pone.0274275.ref027","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1101\/gad.212746.112","article-title":"Comparative genomics in Chlamydomonas and Plasmodium identifies an ancient nuclear envelope protein family essential for sexual reproduction in protists, fungi, plants, and vertebrates","volume":"27","author":"J Ning","year":"2013","journal-title":"Genes Dev"},{"key":"pone.0274275.ref028","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2017.01.024","article-title":"The Ancient Gamete Fusogen HAP2 Is a Eukaryotic Class II Fusion Protein","volume":"168","author":"J F\u00e9dry","year":"2017","journal-title":"Cell"},{"key":"pone.0274275.ref029","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ijpara.2012.09.002","article-title":"Measuring the blockade of malaria transmission\u2013An analysis of the Standard Membrane Feeding Assay","volume":"42","author":"T Churcher","year":"2012","journal-title":"Int J Parasitol"},{"key":"pone.0274275.ref030","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1016\/j.celrep.2017.11.024","article-title":"Targeting the Conserved Fusion Loop of HAP2 Inhibits the Transmission of Plasmodium berghei and falciparum","volume":"21","author":"F Angrisano","year":"2017","journal-title":"Cell Rep"},{"key":"pone.0274275.ref031","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1128\/IAI.01056-13","article-title":"Functional Comparison of Plasmodium falciparum Transmission-Blocking Vaccine Candidates by the Standard Membrane-Feeding Assay","volume":"81","author":"K Miura","year":"2013","journal-title":"Infect Immun"},{"key":"pone.0274275.ref032","doi-asserted-by":"crossref","first-page":"601","DOI":"10.4155\/tde-2016-0037","article-title":"Linear and branched polyacrylates as a delivery platform for peptide-based vaccines","volume":"7","author":"S Chandrudu","year":"2016","journal-title":"Ther Deliv"},{"key":"pone.0274275.ref033","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0264-410X(97)00186-2","article-title":"Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo","volume":"15","author":"MF del Guercio","year":"1997","journal-title":"Vaccine"},{"key":"pone.0274275.ref034","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1074-7613(94)80017-0","article-title":"Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides","volume":"1","author":"J Alexander","year":"1994","journal-title":"Immunity"},{"key":"pone.0274275.ref035","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1747-0285.2012.01423.x","article-title":"Conformation-specific Display of 4E10 and 2F5 Epitopes on Self-assembling Protein Nanoparticles as a Potential HIV Vaccine","volume":"80","author":"N Wahome","year":"2012","journal-title":"Chem Biol Drug Des"},{"key":"pone.0274275.ref036","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0166-6851(93)90077-B","article-title":"High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction","volume":"61","author":"G Snounou","year":"1993","journal-title":"Mol Biochem Parasitol"},{"key":"pone.0274275.ref037","doi-asserted-by":"crossref","first-page":"106126","DOI":"10.1016\/j.pep.2022.106126","article-title":"Optimization of the heterologous expression and purification of Plasmodium falciparum generative cell specific 1 in Escherichia coli","volume":"198","author":"M Ayoub Meigouni","year":"2022","journal-title":"Protein Expr Purif"},{"key":"pone.0274275.ref038","first-page":"1895","article-title":"Thermostability and Aliphatic Index of Globular Proteins","volume":"88","author":"A. Ikai","year":"1980","journal-title":"J Biochem"},{"key":"pone.0274275.ref039","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(15)00725-4","article-title":"Public health impact and cost-effectiveness of the RTS,S\/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models","volume":"387","author":"MA Penny","year":"2016","journal-title":"Lancet"},{"key":"pone.0274275.ref040","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ijpara.2021.01.006","article-title":"A review of combination adjuvants for malaria vaccines: a promising approach for vaccine development","volume":"51","author":"S Pirahmadi","year":"2021","journal-title":"Int J Parasitol"},{"key":"pone.0274275.ref041","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.nano.2006.04.007","article-title":"Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles","volume":"2","author":"S Raman","year":"2006","journal-title":"Nanomedicine Nanotechnology, Biol Med"},{"key":"pone.0274275.ref042","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0022-2836(02)00114-6","article-title":"Improving Coiled-coil Stability by Optimizing Ionic Interactions","volume":"318","author":"P Burkhard","year":"2002","journal-title":"J Mol Biol"},{"key":"pone.0274275.ref043","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1016\/j.vaccine.2017.02.040","article-title":"Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants","volume":"35","author":"L Seth","year":"2017","journal-title":"Vaccine"},{"key":"pone.0274275.ref044","doi-asserted-by":"crossref","first-page":"e48304","DOI":"10.1371\/journal.pone.0048304","article-title":"Protective Antibody and CD8+ T-Cell Responses to the Plasmodium falciparum Circumsporozoite Protein Induced by a Nanoparticle Vaccine","volume":"7","author":"SA Kaba","year":"2012","journal-title":"PLoS One"},{"key":"pone.0274275.ref045","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.vaccine.2017.12.001","article-title":"Self-assembling protein nanoparticles with built-in flagellin domains increases protective efficacy of a Plasmodium falciparum based vaccine","volume":"36","author":"SA Kaba","year":"2018","journal-title":"Vaccine"},{"key":"pone.0274275.ref046","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/j.vaccine.2014.03.092","article-title":"Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice","volume":"32","author":"K El Bissati","year":"2014","journal-title":"Vaccine"},{"key":"pone.0274275.ref047","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.eurpolymj.2017.02.014","article-title":"The application of self-assembled nanostructures in peptide-based subunit vaccine development","volume":"93","author":"G Zhao","year":"2017","journal-title":"Eur Polym J"},{"key":"pone.0274275.ref048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-3155-10-42","article-title":"Encapsulation of gold nanoparticles into self-assembling protein nanoparticles","volume":"10","author":"Y Yang","year":"2012","journal-title":"J Nanobiotechnology"},{"key":"pone.0274275.ref049","first-page":"e60103","article-title":"Production of E. coli -expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation. JoVE","author":"CP Karch","year":"2019","journal-title":"Journal Vis Exp"},{"key":"pone.0274275.ref050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1875933500902010015","article-title":"Design of Peptide Nanoparticles Using Simple Protein Oligomerization Domains","volume":"2","author":"S Raman","year":"2009","journal-title":"Open Nanomed J"},{"key":"pone.0274275.ref051","first-page":"1","article-title":"Design and optimization of peptide nanoparticles","volume":"13","author":"TAPF Doll","year":"2015","journal-title":"J Nanobiotechnology"},{"key":"pone.0274275.ref052","doi-asserted-by":"crossref","first-page":"161092","DOI":"10.1098\/rsos.161092","article-title":"Classification of self-assembling protein nanoparticle architectures for applications in vaccine design","volume":"4","author":"G Indelicato","year":"2017","journal-title":"R Soc Open Sci"},{"key":"pone.0274275.ref053","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bpj.2015.10.057","article-title":"Principles Governing the Self-Assembly of Coiled-Coil Protein Nanoparticles","volume":"110","author":"G Indelicato","year":"2016","journal-title":"Biophys J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0274275","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T17:32:40Z","timestamp":1663003960000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0274275"}},"subtitle":[],"editor":[{"given":"Takafumi","family":"Tsuboi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,12]]},"references-count":53,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0274275","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,12]]}}}